Telomere length has been proposed to signal entry into cellular senescence. Expression of the human telomerase subunit, hTERT, in primary cells now shows that these cells bypass senescence. Address [1, 2] . I shall examine the development of the hypothesis, the recent evidence supporting it, and its implications.
What do chickens, human skin, subway trains and bacteriophage have in common? This unlikely cast of players sets the stage upon which the model that telomere length signals cellular senescence was built. Two recent papers provide evidence that telomere shortening in human cells does indeed signal cells to enter 'senescence' [1, 2] . I shall examine the development of the hypothesis, the recent evidence supporting it, and its implications.
The cells
In 1908, Alexis Carrel, a Nobel prize-winning surgeon, became interested in the growth of cells in culture. In 1912, he established a culture of chick heart fibroblast cells, which he then grew in the laboratory for 34 years. This work led to the general acceptance of the notion that vertebrate cells can divide indefinitely in culture. As individual cells were immortal, Carrel reasoned that aging is "an attribute of the multicellular body as a whole" (reviewed in [3] ).
In 1961, this concept of cell immortality was challenged by experiments published by Hayflick and Moorehead [4] . They found that fibroblast cultures derived from human skin would divide 40 to 50 times, and then stop and "undergo senescence". Further work showed that cells from older people underwent fewer divisions than cells from younger people, suggesting that it was the total number of divisions since birth, not total divisions in culture, that was important [5] .
When subsequent work showed that Carrel's immortal chicken cell cultures were not reproducible, Hayflick's senescence model eventually became accepted (reviewed in [3] ). Two important questions emerged from the nascent field of cellular senescence. First, what is the role of cellular senescence in humans? Does the limited capacity of cells to divide relate to human aging, or is it a mechanism to prevent tumor formation (reviewed in [6] [7] .
Far away from Harvard at the Gamelaya Institute in the then Soviet Union, Alexei Olovnikov was also thinking about DNA molecules -while waiting for a subway train [8] . When he heard the train approaching, he suddenly saw a parallel with DNA replication. If the train engine were replicating the DNA track, the first bit of DNA would not be replicated as it would be underneath the engine [8] . Interestingly, although both models recognized a problem with DNA ends, Olovnikov's model predicted a problem at the beginning of DNA replication, whereas Watson's predicted a problem at the end. Olovnikov knew of Hayflick's work on cellular senescence and recognized that the end replication problem might trigger the Hayflick limit -too much chromosome shortening might cause cellular senescence [9] .
The telomere
In 1978, Blackburn, working in Gall's laboratory at Yale, was interested in determining the DNA sequence that allowed the Tetrahymena rDNA molecule to be maintained as a linear chromosome. Her work led to the finding that chromosome ends, or telomeres, are made of simple repeated DNA sequences [10] . It soon became apparent that this motif was conserved throughout evolution and that a common mechanism might exist in eukaryotes for the maintenance of telomeres. In 1984, working in Blackburn's laboratory, I identified an enzyme, telomerase, that added telomere repeats onto chromosome ends. We suggested that telomerase would compensate for the incomplete replication of chromosome ends. This would explain the telomere length maintenance seen in organisms such as Tetrahymena and yeast [11] . Telomerase is an unusual polymerase; it contains an integral RNA component that provides the template for synthesis of telomere repeats [12] .
The connection
Insight into the molecular structure of the ends of human chromosomes came from using a probe representing a sequence on the Y chromosome that was near enough to the telomere to follow the terminal chromosome fragment. Using this probe, Cooke found that telomeres in germline tissue (sperm) were longer than telomeres in somatic tissue (blood cells). He speculated that telomere length is tissue-specific and that telomere length shortens between germline and somatic tissues [13] . Subsequently, the identification of the simple-sequence telomere repeat from human cells [14] allowed a simple analysis of telomere length and cell senescence. Harley, Futcher, and I then found that telomeres indeed shorten as normal human fibroblasts grow in culture [15] . Telomeres were also shorter in skin samples from older people than from younger people, suggesting that the shortening was not a tissue culture phenomenon [15, 16] . At about the same time, Hastie et al. [16] and de Lange et al. [17] found that tumor samples had shorter telomeres than adjacent normal tissue, providing the first suggestion of a connection between telomeres and cancer.
The synthesis
In the early 1990s, a model emerged which had two parts: one that related telomeres to cell senescence, and the other that linked telomeres, telomerase and cancer (reviewed in [18] ; Figure 1) . The model stated that telomeres shorten during growth of primary fibroblasts, because of the end replication problem and the absence of telomerase. Germline cells, in contrast, have telomerase and thus maintain telomere length. Telomere shortening signals cells to senesce. Senescence, however, can be bypassed by expression of viral oncogenes. During this extended life span, telomeres continue to shorten until the cell culture reaches a crisis. At crisis many cells die. The few cells that survive, can divide indefinitely. These cells have activated telomerase and maintain or even elongate telomeres. With the demonstration that tumor cells, like immortal cells in culture, express the enzyme, telomerase was proposed as a potential target for anti-cancer therapy [15] . The recent reports by Bodner et al. [1] and Vaziri and Benchimol [2] provide strong evidence for the first part of this hypothesis -that telomere shortening is a mechanism that limits cell division capacity.
The experiment
To test whether telomere length signals cell senescence, several groups have sought to elongate telomeres artificially and determine whether cellular life-span would be extended. The recent isolation of the catalytic component of telomerase allowed telomere length to be altered in human cells. The catalytic component of Euplotes telomerase was isolated by Lingner in Cech's laboratory [19] , and the sequence of the 123 kDa protein was shown to be similar to Est2p of budding yeast, which is required for telomere maintenance [20] . The homology of p123 and Est2p to reverse transcriptase motifs allowed the elegant demonstration that these proteins represent the catalytic subunits of telomerase [21] . When a human cDNA fragment encoding a protein sequence similar to p123 was deposited in Genbank, several groups quickly cloned the corresponding gene, hTERT [22] [23] [24] [25] and showed that it encodes an essential component of human telomerase [24, 26] . This set the stage for testing the role of telomeres in cell senescence by forcing telomerase expression in primary human cells.
The cloning of hTERT prompted a flurry of experiments that resulted in a number of remarkable findings. The initial surprise was that simply expressing hTERT in primary cells led to telomerase activity [2, 26, 27] . Although telomerase is composed of both protein and RNA, the RNA component is often present even in cells that do not normally have activity [28] . Apparently this level of RNA is sufficient for telomerase activity when hTERT is present. The next surprise was that the presence of telomerase activity in primary cells was sufficient for telomere elongation [1, 2] . Although this was the result that many had hoped for, recent evidence suggested that the availability of telomere-binding proteins might limit telomere growth [29] . At last the experiment could be done: the frequency of senescent primary cell clones was compared between cell that had telomerase activity and Dispatch R179
Figure 1
The telomere hypothesis of cell senescence and immortalization proposes that: (1) Telomeres are maintained in the germline because of the presence of telomerase. those that did not. Cells with longer telomeres did not undergo senescence, whereas those with short telomeres did [1, 2] . Telomere length is therefore one criterion that determines entry into cell senescence (Figure 2 ).
The interpretation and the future
Like all good experiments, this discovery raises more questions than it answers. At the simplest level there are detailed questions about how telomere length might signal entry into senescence. What is measured? The length of the shortest telomere? The average telomere length, or the total number of telomere repeats? How is the signal sent and what are the pathways that respond? The medical implications of the experiment are also important to explore. Extending the life span of primary cells could significantly enhance the ability to grow cells ex vivo for autologous transplantation. This technique could be useful in growing extra skin cells for burn victims, for example.
Telomerase has also been proposed for gene therapy to extend the life span of cells in vivo [1] . Before such approaches are implemented, it will be important to understand better why cells senesce. If cellular senescence indeed is a mechanism of tumor suppression (reviewed in [6] ), activation of telomerase might pre-dispose cells to tumor formation by overcoming one of the many steps required for transformation.
Recent experiments have shown that mouse cells lacking telomerase become transformed and cause tumors [30] . Does this suggest that telomerase activation will not play a role in the transformation of human cells? Probably not, because there are important differences between human and mouse cells. First the length of telomere repeat sequence on mouse chromosomes is two-to-five times longer than human telomere tracts [31] [32] [33] , suggesting mouse cells may be less sensitive than human cells to telomere shortening. Second, mouse cells immortalize much more readily than human cells. Humans, as a longlived species, may have evolved have additional mechanisms to protect against cell immortalization and cancer. Human cells may use telomeres to signal senescence and thus limit cells growth, while mouse cells do not. With the recent advances in understanding the basic structure and synthesis of telomeres, it is now possible to test whether extending cell life span might predispose human cells to tumor formation.
